Community pharmacists' knowledge of substandard and falsified medicines in clinical practice: a cross-sectional survey in Saudi Arabia.
Alsaeed Bashayr AliRavina BarrettPublished in: The International journal of pharmacy practice (2023)
Community pharmacists' self-reported awareness and knowledge of SFs in Saudi Arabia was inadequate; this deficiency may affect their ability to protect their patients from potential harm by combating SFs. As a regulatory body responsible for issues related to SFs, the Saudi Food and Drug Authority should develop an action plan to equip community pharmacists with training in SFs to enhance their ability to respond to SFs.
Keyphrases
- healthcare
- mental health
- end stage renal disease
- clinical practice
- ejection fraction
- newly diagnosed
- chronic kidney disease
- general practice
- prognostic factors
- peritoneal dialysis
- transcription factor
- primary care
- drug induced
- risk assessment
- patient reported outcomes
- virtual reality
- saudi arabia
- patient reported
- climate change